PDL BioPharma: Another big win for Dan Loeb
TheDeal.com has a good summary of Loeb's battle with PDL, but these are some of my favorite snippets from Loeb's 13-D letters to the company's executives and directors. Every public battle that Loeb launches with a public company culminates in a "greatest hits" collection containing Loeb's best barbs directed at the company's brass:
... it is critical that you, the non-management directors, exercise your fiduciary duty and finally take action: terminate Mr. McDade before he is allowed to destroy shareholder value at our Company for even one more day. [ -- a request that was fulfilled with McDade's resignation.]
Mr. McDade's record of incompetence, egregiously bad business judgment and serious ethical lapses has been well documented by one of PDL's founders, numerous current and former employees, as well as by Third Point.
Mr. McDade lacks the ability to communicate with the investment community effectively in part because he has a poor understanding of even basic financial concepts...
For an interesting analysis of Dan Loeb as a poet, check out this piece from DealBreaker.
Recent Posts
- LBO debt crisis may be on the horizon (10/10/2007)
- McAfee pays $350 million for Safeboot (10/10/2007)
- Buyout shops load up on fashion producers (10/10/2007)
- Can Cerberus break new ground for Chrysler with the UAW? (10/09/2007)
- Sallie Mae(SLM) is not going to take it anymore from JC Flowers (10/09/2007)
Add your comments
Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.
When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br> tags.
BloggingBuyouts is provided for informational purposes only. Nothing on the service is intended to provide personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio or securities, transaction, investment strategy or other matter. You are solely responsible for any investment decisions that you make. The contributors who provide the content of BloggingBuyouts may, from time to time, hold positions in the securities discussed at the time of writing and they may trade for their own accounts. Such holdings will be disclosed at the time of writing. By using the site, you agree to abide to BloggingBuyouts' Terms of Use.